Formula for Success: Minnesota Biotech & Life Sciences
Thursday, March 22, 2018
Minnesota cements status as national leader in bioscience research and discovery
A University of Minnesota spinout company is working to develop an artificial liver that could dramatically reduce the number of patients who die waiting for a liver transplant. Another Minnesota company has developed a novel means of serving primary care to low-income seniors, keeping them healthy while saving them money.
These are just two examples of the innovations emerging from Minnesota’s bioscience industry, which, with a nearly $23 billion annual impact and 167,000 direct and indirect jobs, is one of the largest in the country. In fact, Minnesota ranks first among states for medical device patents per capita and second for bioscience-related patents.
Center of Innovation
Thanks to a highly specialized workforce as well as a robust network of resources and business incentives, Minnesota has become a global center of innovation in medical device production, pharma/biologics, bioagriculture, bioinformatics and health IT.
Health IT firm Zipnosis developed a software platform that enables virtual medical office visits. The Minneapolis-based company is a leader in virtual care, and its software will allow providers to remotely triage and treat patients.
Category: Agralite, Arrowhead, BENCO, Brown, Connexus, Light and Power, Crow Wing, Dakota, East Central, Federated, Goodhue, Itasca, Kandiyohi, Lake Country, Lake Region, McLeod, Meeker, Mille Lacs, Minnesota Valley, Nobles, North Itasca, Redwood, Runestone, South Central, Stearns Electric, Steele, Todd, Wright Hennepin